CEO Scott Plesha to attend Piper Sandler Spring Biopharma Symposium on April 16, 2026

Pelthos Therapeutics Inc.

CEO will hold one-on-one investor meetings at conference in Boston.
Corporate presentation made available on company website but contains no new material disclosures.
No financial results, pipeline updates, or material events announced.

item 7.01 item 9.01

Pelthos Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001919246-26-000060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.